Supplementary Table 1 from Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations
Year: 2023
Type: supplementary-materials
Abstract: Summary of the clinicopathological characteristics of the patients with lung adecarcinoma examined for EZH2 expression and KRAS mutations
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361850713